日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Improvement of humoral immunity by repeated dose-intensified COVID-19 vaccinations in primary non- to low-responders and B cell deficient rheumatic disease patients

对初次接种疫苗无应答或低应答者以及B细胞缺陷型风湿病患者,通过重复接种强化剂量的COVID-19疫苗可改善体液免疫。

Ten Hagen, Alexander; Hermann, Sandra; Habermann, Elisa; Frommert, Leonie Maria; Arumahandi de Silva, Amanthi Nadira; Scholz, Veronika; Ghannam, Khetam; Klotsche, Jens; Zernicke, Jan; Alexander, Tobias; Burmester, Gerd-R; Albach, Fredrik N; Biesen, Robert

Performance of commercial SARS-CoV-2 wild-type and Omicron BA.1 antibody assays compared with pseudovirus neutralization tests

商业化SARS-CoV-2野生型和Omicron BA.1抗体检测方法与假病毒中和试验的性能比较

Habermann, E; Frommert, L M; Ghannam, K; Nguyen My, L; Gieselmann, L; Tober-Lau, P; Klotsche, J; Arumahandi de Silva, A N; Ten Hagen, A; Zernicke, J; Kurth, F; Sander, L E; Klein, F; Burmester, G R; Biesen, R; Albach, F N

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases

暂停使用甲氨蝶呤可提高老年风湿病患者接种新冠疫苗的免疫原性

Arumahandi de Silva, Amanthi Nadira; Frommert, Leonie Maria; Albach, Fredrik N; Klotsche, Jens; Scholz, Veronika; Jeworowski, Lara Maria; Schwarz, Tatjana; Ten Hagen, Alexander; Zernicke, Jan; Corman, Victor Max; Drosten, Christian; Burmester, Gerd-Rüdiger; Biesen, Robert

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease

疫苗类型和免疫抑制疗法(而非诊断)对风湿病患者接种 COVID-19 疫苗后的抗体反应有显著影响。

Frommert, Leonie Maria; Arumahandi de Silva, Amanthi Nadira; Zernicke, Jan; Scholz, Veronika; Braun, Tanja; Jeworowski, Lara Maria; Schwarz, Tatjana; Tober-Lau, Pinkus; Ten Hagen, Alexander; Habermann, Elisa; Kurth, Florian; Sander, Leif Erik; Corman, Victor Max; Burmester, Gerd-Rüdiger; Biesen, Robert; Albach, Fredrik N; Klotsche, Jens